S272: SAFETY AND PRELIMINARY PHARMACODYNAMIC EFFECTS OF THE FERROPORTIN INHIBITOR VAMIFEPORT (VIT-2763) IN PATIENTS WITH NON-TRANSFUSION-DEPENDENT BETA THALASSEMIA (NTDT): RESULTS FROM A PHASE 2A STUDY
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000843980.18213.bf |
| _version_ | 1797287874347925504 |
|---|---|
| author | A. Taher A. Kourakli-Symeonidis A. Tantiworawit P. Wong P. Szecsödy |
| author_facet | A. Taher A. Kourakli-Symeonidis A. Tantiworawit P. Wong P. Szecsödy |
| author_sort | A. Taher |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:41:07Z |
| format | Article |
| id | doaj.art-0587664156944715b3c14e7f1d16ec20 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:41:07Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-0587664156944715b3c14e7f1d16ec202024-03-02T03:51:53ZengWileyHemaSphere2572-92412022-06-01617317410.1097/01.HS9.0000843980.18213.bf202206003-00173S272: SAFETY AND PRELIMINARY PHARMACODYNAMIC EFFECTS OF THE FERROPORTIN INHIBITOR VAMIFEPORT (VIT-2763) IN PATIENTS WITH NON-TRANSFUSION-DEPENDENT BETA THALASSEMIA (NTDT): RESULTS FROM A PHASE 2A STUDYA. Taher0A. Kourakli-Symeonidis1A. Tantiworawit2P. Wong3P. Szecsödy41 American University of Beirut Medical Center, Beirut, Lebanon2 University of Patras – Rio Regional University Hospital, Rio, Greece3 Chiang Mai University – Faculty of Medicine, Chiang Mai4 Naresuan University Hospital, Mueang Phitsanulok, Thailand5 Vifor Pharma AG, Glattburg, Switzerlandhttp://journals.lww.com/10.1097/01.HS9.0000843980.18213.bf |
| spellingShingle | A. Taher A. Kourakli-Symeonidis A. Tantiworawit P. Wong P. Szecsödy S272: SAFETY AND PRELIMINARY PHARMACODYNAMIC EFFECTS OF THE FERROPORTIN INHIBITOR VAMIFEPORT (VIT-2763) IN PATIENTS WITH NON-TRANSFUSION-DEPENDENT BETA THALASSEMIA (NTDT): RESULTS FROM A PHASE 2A STUDY HemaSphere |
| title | S272: SAFETY AND PRELIMINARY PHARMACODYNAMIC EFFECTS OF THE FERROPORTIN INHIBITOR VAMIFEPORT (VIT-2763) IN PATIENTS WITH NON-TRANSFUSION-DEPENDENT BETA THALASSEMIA (NTDT): RESULTS FROM A PHASE 2A STUDY |
| title_full | S272: SAFETY AND PRELIMINARY PHARMACODYNAMIC EFFECTS OF THE FERROPORTIN INHIBITOR VAMIFEPORT (VIT-2763) IN PATIENTS WITH NON-TRANSFUSION-DEPENDENT BETA THALASSEMIA (NTDT): RESULTS FROM A PHASE 2A STUDY |
| title_fullStr | S272: SAFETY AND PRELIMINARY PHARMACODYNAMIC EFFECTS OF THE FERROPORTIN INHIBITOR VAMIFEPORT (VIT-2763) IN PATIENTS WITH NON-TRANSFUSION-DEPENDENT BETA THALASSEMIA (NTDT): RESULTS FROM A PHASE 2A STUDY |
| title_full_unstemmed | S272: SAFETY AND PRELIMINARY PHARMACODYNAMIC EFFECTS OF THE FERROPORTIN INHIBITOR VAMIFEPORT (VIT-2763) IN PATIENTS WITH NON-TRANSFUSION-DEPENDENT BETA THALASSEMIA (NTDT): RESULTS FROM A PHASE 2A STUDY |
| title_short | S272: SAFETY AND PRELIMINARY PHARMACODYNAMIC EFFECTS OF THE FERROPORTIN INHIBITOR VAMIFEPORT (VIT-2763) IN PATIENTS WITH NON-TRANSFUSION-DEPENDENT BETA THALASSEMIA (NTDT): RESULTS FROM A PHASE 2A STUDY |
| title_sort | s272 safety and preliminary pharmacodynamic effects of the ferroportin inhibitor vamifeport vit 2763 in patients with non transfusion dependent beta thalassemia ntdt results from a phase 2a study |
| url | http://journals.lww.com/10.1097/01.HS9.0000843980.18213.bf |
| work_keys_str_mv | AT ataher s272safetyandpreliminarypharmacodynamiceffectsoftheferroportininhibitorvamifeportvit2763inpatientswithnontransfusiondependentbetathalassemiantdtresultsfromaphase2astudy AT akouraklisymeonidis s272safetyandpreliminarypharmacodynamiceffectsoftheferroportininhibitorvamifeportvit2763inpatientswithnontransfusiondependentbetathalassemiantdtresultsfromaphase2astudy AT atantiworawit s272safetyandpreliminarypharmacodynamiceffectsoftheferroportininhibitorvamifeportvit2763inpatientswithnontransfusiondependentbetathalassemiantdtresultsfromaphase2astudy AT pwong s272safetyandpreliminarypharmacodynamiceffectsoftheferroportininhibitorvamifeportvit2763inpatientswithnontransfusiondependentbetathalassemiantdtresultsfromaphase2astudy AT pszecsody s272safetyandpreliminarypharmacodynamiceffectsoftheferroportininhibitorvamifeportvit2763inpatientswithnontransfusiondependentbetathalassemiantdtresultsfromaphase2astudy |